CU24006B1 - Un método para la obtención de células dianas reprogramadas - Google Patents

Un método para la obtención de células dianas reprogramadas

Info

Publication number: CU24006B1
Authority: CU; Cuba
Prior art keywords: cells; patient; obtaining; compromised; transdifferentiated
Prior art date: 2009-10-19

Application number

CU2012000063A

Other languages

English (en)

Spanish (es)

Other versions

CU20120063A7 (es

Inventor

Ilham Mohamed Saleh Saeed Abuljadayel

Original Assignee

Tristem Trading Cyprus Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-10-19

Filing date

2012-04-19

Publication date

2014-06-27

2012-04-19 Application filed by Tristem Trading Cyprus Ltd filed Critical Tristem Trading Cyprus Ltd

2012-10-15 Publication of CU20120063A7 publication Critical patent/CU20120063A7/es

2014-06-27 Publication of CU24006B1 publication Critical patent/CU24006B1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Developmental Biology & Embryology (AREA)
Virology (AREA)
Immunology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Biotechnology (AREA)
Hematology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Molecular Biology (AREA)
Oncology (AREA)

CU2012000063A 2009-10-19 2012-04-19 Un método para la obtención de células dianas reprogramadas CU24006B1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/GB2009/051396 WO2011048350A1 (fr)	2009-10-19	2009-10-19	Traitement à l'aide de cellules adultes matures reprogrammées

Publications (2)

Publication Number	Publication Date
CU20120063A7 CU20120063A7 (es)	2012-10-15
CU24006B1 true CU24006B1 (es)	2014-06-27

Family

ID=42199514

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CU2012000063A CU24006B1 (es)	2009-10-19	2012-04-19	Un método para la obtención de células dianas reprogramadas

Country Status (17)

Country	Link
EP (1)	EP2490702A1 (fr)
JP (1)	JP6073135B2 (fr)
KR (1)	KR101766203B1 (fr)
CN (1)	CN102647989A (fr)
AU (1)	AU2009354350B2 (fr)
CA (1)	CA2781522A1 (fr)
CH (1)	CH704227B1 (fr)
CU (1)	CU24006B1 (fr)
IL (1)	IL218902A (fr)
MA (1)	MA33740B1 (fr)
MX (1)	MX2012004522A (fr)
PH (1)	PH12012500714A1 (fr)
RU (1)	RU2635317C2 (fr)
TN (1)	TN2012000157A1 (fr)
UA (1)	UA109265C2 (fr)
WO (1)	WO2011048350A1 (fr)
ZA (1)	ZA201202664B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2016044681A1 (fr) *	2014-09-18	2016-03-24	North Carolina State University	Sphéroïdes du poumon de mammifère et cellules sphéroïdes du poumon et leurs utilisations
JP6113133B2 (ja)	2014-11-06	2017-04-12	日本メナード化粧品株式会社	幹細胞の未分化状態維持剤及び増殖促進剤
CN108290939B (zh)	2015-10-16	2023-01-13	纽约市哥伦比亚大学理事会	用于抑制谱系特异性抗原的组合物和方法
CN107114355A (zh) *	2016-08-01	2017-09-01	北京世纪劲得生物技术有限公司	一种脂肪细胞保护液及其制备方法
KR102709603B1 (ko) *	2017-02-28	2024-09-27	보르 바이오파마 인크.	계통 특이적 단백질의 억제를 위한 조성물 및 방법
CN109731012A (zh) *	2017-10-30	2019-05-10	邹兆中	提高生物免疫治疗有效物质活性的方法
CN109706119B (zh) *	2018-04-13	2020-11-27	诺未科技（北京）有限公司	扩增造血干细胞的培养体系、方法及其用途
CA3110837A1 (fr)	2018-08-28	2020-03-05	Vor Biopharma Inc.	Cellules souches hematopoietiques genetiquement modifiees et utilisations associees
KR20200025210A (ko) *	2018-08-29	2020-03-10	주식회사 스템모어	모유두 세포의 배양용 조성물 및 이를 이용한 모유두 세포의 배양 방법
WO2021240204A1 (fr) *	2020-05-23	2021-12-02	Pakravan Nafiseh	Tête de sperme pour la résolution d'une inflammation, la régénération tissulaire, la régénération et la restauration de la fonction tissulaire : nouvelle approche de thérapie cellulaire
CN114231481B (zh) *	2021-12-21	2023-07-18	中国人民解放军总医院	一种重编程真皮成纤维细胞为内皮祖细胞的化学诱导方法
WO2023217125A1 (fr) *	2022-05-10	2023-11-16	上海赛立维生物科技有限公司	Cellule de type précurseur de la prostate et préparation cellulaire, procédé de préparation associé et utilisation associée
WO2024050517A1 (fr) *	2022-09-02	2024-03-07	The University Of North Carolina At Chapel Hill	Procédés de fabrication et d'utilisation de lymphocytes b reprogrammés anticancéreux
WO2025143018A1 (fr) *	2023-12-28	2025-07-03	サントリーホールディングス株式会社	Composition pour supprimer un déclin de la curiosité ou améliorer la curiosité

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5554512A (en) *	1993-05-24	1996-09-10	Immunex Corporation	Ligands for flt3 receptors
US7112440B2 (en) *	1995-02-02	2006-09-26	Ghazi Jaswinder Dhoot	Method of increasing the relative number of CD45 low cells in a cell population
US9068164B1 (en) *	1995-02-02	2015-06-30	Tristem Trading (Cyprus) Limited	Method of preparing an undifferentiated cell
GB9502022D0 (en) *	1995-02-02	1995-03-22	Abuljadayel Ilham M S	A method for preparing lymphohaematopoietic progenitor cells
JPH10503053A (ja) *	1995-05-02	1998-03-17	フィリップスエレクトロニクスネムローゼフェンノートシャップ	カラー陰極線管
US20050037490A1 (en) *	1999-10-29	2005-02-17	Lawrence Rosenberg	Medium for preparing dedifferentiated cells
TWI288779B (en) *	2002-03-28	2007-10-21	Blasticon Biotech Forschung	Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
US20080112937A1 (en) *	2004-07-22	2008-05-15	Lewis T Williams	Method of Producing Autologous Embryonic Stem Cells
EP2414510A4 (fr) *	2009-04-03	2013-04-17	Mclean Hospital Corp	Cellules souches pluripotentes induites

2009
- 2009-10-19 RU RU2012120713A patent/RU2635317C2/ru not_active IP Right Cessation
- 2009-10-19 AU AU2009354350A patent/AU2009354350B2/en not_active Ceased
- 2009-10-19 CH CH00524/12A patent/CH704227B1/fr not_active IP Right Cessation
- 2009-10-19 KR KR1020127012911A patent/KR101766203B1/ko not_active Expired - Fee Related
- 2009-10-19 PH PH1/2012/500714A patent/PH12012500714A1/en unknown
- 2009-10-19 WO PCT/GB2009/051396 patent/WO2011048350A1/fr not_active Ceased
- 2009-10-19 MX MX2012004522A patent/MX2012004522A/es unknown
- 2009-10-19 CA CA2781522A patent/CA2781522A1/fr not_active Abandoned
- 2009-10-19 EP EP09736651A patent/EP2490702A1/fr not_active Withdrawn
- 2009-10-19 CN CN2009801630439A patent/CN102647989A/zh active Pending
- 2009-10-19 JP JP2012534757A patent/JP6073135B2/ja not_active Expired - Fee Related
- 2009-10-19 UA UAA201205968A patent/UA109265C2/uk unknown
2012
- 2012-03-28 IL IL218902A patent/IL218902A/en not_active IP Right Cessation
- 2012-04-04 TN TNP2012000157A patent/TN2012000157A1/en unknown
- 2012-04-12 ZA ZA2012/02664A patent/ZA201202664B/en unknown
- 2012-04-19 CU CU2012000063A patent/CU24006B1/es active IP Right Grant
- 2012-05-11 MA MA34857A patent/MA33740B1/fr unknown

Also Published As

Publication number	Publication date
CH704227B1 (fr)	2015-05-15
UA109265C2 (uk)	2015-08-10
WO2011048350A1 (fr)	2011-04-28
PH12012500714A1 (en)	2012-10-29
ZA201202664B (en)	2013-02-27
MA33740B1 (fr)	2012-11-01
AU2009354350A1 (en)	2012-04-19
RU2635317C2 (ru)	2017-11-10
CA2781522A1 (fr)	2011-04-28
IL218902A0 (en)	2012-06-28
JP6073135B2 (ja)	2017-02-01
CN102647989A (zh)	2012-08-22
JP2013508343A (ja)	2013-03-07
EP2490702A1 (fr)	2012-08-29
TN2012000157A1 (en)	2013-12-12
KR20120099686A (ko)	2012-09-11
KR101766203B1 (ko)	2017-08-08
MX2012004522A (es)	2012-05-08
CU20120063A7 (es)	2012-10-15
AU2009354350B2 (en)	2015-09-03
RU2012120713A (ru)	2013-11-27
IL218902A (en)	2017-06-29

Publication	Publication Date	Title
CU24006B1 (es)	2014-06-27	Un método para la obtención de células dianas reprogramadas
CO6511283A2 (es)	2012-08-31	Primidinas sustituidas útiles en el tratamiento de enfermedades tales como cancer
UY33199A (es)	2011-08-31	5-alquinil-pirimidinas.
UY32958A (es)	2011-05-31	Derivados de glicósido y usos de los mismos.
ECSP10010475A (es)	2010-10-30	Derivados de azetidina y ciclobutano como inhibidores de jak
ECSP12011830A (es)	2012-06-29	Nuevos compuestos.
DOP2017000013A (es)	2017-02-15	Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
MX378354B (es)	2025-03-10	Mejoramiento de autofagia o incremento de longevidad por administracion de urolitinas o precursores de las mismas.
ECSP12012230A (es)	2012-11-30	Proteína de fusión robo1-fc y su utilización en el tratamiento de tumores
ECSP11010816A (es)	2011-03-31	Nuevos Compuestos
UY32009A (es)	2010-02-26	5-alquinil-pirimidinas
UY32240A (es)	2010-06-30	Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
UY32747A (es)	2011-01-31	2-carboxamida-cicloamino-ureas sustituidas
BR112014004224A2 (pt)	2017-03-21	aparelhos e métodos para tratamento de estacas de caules de cana-de açúcar
CR20130094A (es)	2013-07-01	Agonistas de adenosina a1 para el tratamiento del glaucoma y la hipertensión ocular
BR112015017830A2 (pt)	2017-11-21	processos e meios para aumentar a tolerância ao estresse e a biomassa em plantas
CO6460762A2 (es)	2012-06-15	5-alquinil-piridinas
CR20110023A (es)	2011-05-10	Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida
UY32878A (es)	2011-03-31	Composiciones para acabado de cuero que comprenden derivados del dioxolano
UY32385A (es)	2010-08-31	Amidas de pirazinona sustituida
UY32186A (es)	2011-05-31	Tratamiento que utiliza celulas adultas maduras reprogramadas
CO6460760A2 (es)	2012-06-15	Tia-triaza-ciclopentazulenos
ECSP12012110A (es)	2012-09-28	5-alquinil-pirimidinas
AR073910A1 (es)	2010-12-09	Tratamiento de diversas enfermedades, usando celulas adultas maduras reprogramadas.
CR20130059A (es)	2013-03-25	Procedimiento para preparar formas enantioméricas de derivados de ácido 2,3-diaminopropiónico

Legal Events

Date	Code	Title	Description
2014-05-19	FG	Grant of patent